Truist Financial Reiterates Buy Rating for Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA)‘s stock had its “buy” rating reiterated by equities researchers at Truist Financial in a research note issued to investors on Monday,Benzinga reports. They currently have a $31.00 target price on the stock, up from their previous target price of $30.00. Truist Financial’s target price indicates a potential upside of 32.96% from the company’s previous close.

Other research analysts have also issued research reports about the stock. Barclays upped their price objective on shares of Privia Health Group from $21.00 to $22.00 and gave the company an “equal weight” rating in a research report on Thursday, October 9th. Citizens Jmp upped their price target on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a report on Friday. Evercore ISI raised their price objective on Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a research report on Friday. Citigroup restated an “outperform” rating on shares of Privia Health Group in a research report on Friday, August 29th. Finally, Weiss Ratings raised Privia Health Group from a “sell (d+)” rating to a “hold (c)” rating in a research report on Friday. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.50.

Privia Health Group Stock Down 0.5%

Shares of PRVA traded down $0.11 during midday trading on Monday, reaching $23.32. 359,567 shares of the stock were exchanged, compared to its average volume of 845,371. The company has a market cap of $2.87 billion, a price-to-earnings ratio of 179.28, a P/E/G ratio of 3.32 and a beta of 0.83. Privia Health Group has a 12-month low of $18.77 and a 12-month high of $26.51. The firm has a 50 day simple moving average of $24.15 and a 200-day simple moving average of $22.76.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $213.61 million for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. Research analysts expect that Privia Health Group will post 0.14 earnings per share for the current fiscal year.

Institutional Trading of Privia Health Group

Several institutional investors have recently bought and sold shares of the stock. US Bancorp DE grew its position in Privia Health Group by 2.4% in the first quarter. US Bancorp DE now owns 18,487 shares of the company’s stock valued at $415,000 after acquiring an additional 429 shares during the period. Wealth Alliance LLC boosted its stake in shares of Privia Health Group by 4.4% in the 3rd quarter. Wealth Alliance LLC now owns 11,979 shares of the company’s stock valued at $298,000 after purchasing an additional 508 shares in the last quarter. Arizona State Retirement System grew its holdings in shares of Privia Health Group by 1.9% in the 3rd quarter. Arizona State Retirement System now owns 28,835 shares of the company’s stock worth $718,000 after purchasing an additional 524 shares during the last quarter. Bank of Montreal Can increased its position in shares of Privia Health Group by 1.9% during the 2nd quarter. Bank of Montreal Can now owns 28,694 shares of the company’s stock worth $660,000 after purchasing an additional 543 shares in the last quarter. Finally, Illinois Municipal Retirement Fund lifted its holdings in Privia Health Group by 1.1% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 55,501 shares of the company’s stock valued at $1,382,000 after purchasing an additional 585 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.